VDO of MEDomics MitoDx: New Test for Mitochondrial Diseases (© MMX, CBS Broadcasting Inc. )
MEDomics MitoDx: New Test for Mitochondrial Diseases (© MMX, CBS Broadcasting Inc. ) Video Clips. Duration : 2.18 Mins.We had a good read. For the benefit of yourself. Be sure to read to the end. I want you to get good knowledge from Family Counselor. MEDomics, LLC announces an innovative test for early diagnosis of mitochondrial diseases, a group of disorders that can result in neurological dysfunction, muscle weakness, gastrointestinal symptoms, migraine headaches, blindness, deafness, and diabetes. The MEDomics mitochondrial genome test, MitoDx™, uses revolutionary NextGen sequencing technology to detect all mutations in any of the 37 mitochondrial DNA genes. The MEDomics team of experts provides interpretation of the functional significance of detected mutations. This comprehensive test offers exceptionally high diagnostic utility for suspected mitochondrial disease, enabling potentially lifesaving therapy and accurate risk counseling. Disease from mutations in mitochondrial DNA is now thought to be common in both adults and children. In childhood, mitochondrial disease is more common than muscular dystrophy or cancer. Most mitochondrial disease may go undiagnosed because a primary care physician does not suspect the disease or because the causative mutation is missed by current methods. To my knowledge, MEDomics is the first laboratory to offer a whole genome clinical diagnostic test utilizing the powerful NextGen sequencing technique says Steve S Sommer, MD, PhD, Founder and President of MEDomics. Mitochondria are the power plants of the cell, providing energy for cellular processes, including growth, and metabolism. Mutations in mitochondrial genes may decrease energy production and affect multiple organs. Since ...
No comments:
Post a Comment